IL17A and cystic fibrosis: We hypothesize that the reduced number of neutrophils in PP-007-treated CF mice could, among other factors, be ascribed to the profound effect of the drug on the levels of IL-17, given the importance of this cytokine in the persistence of lung neutrophilia.